International Society For Pharmaceutical Engineering Inc
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2011 | 127,379 | 166,544 | −39,165 | 7.2 | — |
| 2012 | 237,294 | 198,953 | 38,341 | 8.3 | 0% |
| 2013 | 135,551 | 164,281 | −28,730 | 8.0 | — |
| 2014 | 201,981 | 156,150 | 45,831 | 11.9 | 0% |
| 2015 | 221,559 | 182,696 | 38,863 | 12.7 | 0% |
| 2016 | 176,699 | 232,940 | −56,241 | 7.1 | 0% |
| 2017 | 214,207 | 227,272 | −13,065 | 6.6 | 0% |
| 2018 | 250,983 | 240,616 | 10,367 | 6.7 | 0% |
| 2019 | 257,391 | 260,616 | −3,225 | 6.1 | 0% |
| 2020 | 29,063 | 63,202 | −34,139 | 18.5 | — |
| 2021 | 86,694 | 98,659 | −11,965 | 10.4 | — |
| 2022 | 372,189 | 273,456 | 98,733 | 8.1 | 0% |
| 2023 | 512,317 | 384,982 | 127,335 | 9.7 | 0% |
In its most recent public year (2023), this organization brought in $127,335 more than it spent. Its reserves stood at about 9.7 months of spending, up from 7.2 in 2011. Staff pay was 0% of spending.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
International Society For Pharmaceutical Engineering Inc's IRS filings as a feed — one entry per filing year, through 2023. Add the address to any feed reader; in Slack, send /feed subscribe with it (pasting the link alone won't subscribe). How this feed works